Bank of New York Mellon’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Buy
235,405
+30,614
+15% +$187K ﹤0.01% 2801
2026
Q1
$1.57M Sell
204,791
-4,431
-2% -$33.9K ﹤0.01% 2947
2025
Q4
$2.03M Buy
209,222
+7,915
+4% +$67.3K ﹤0.01% 2823
2025
Q3
$843K Sell
201,307
-5,255
-3% -$33.6K ﹤0.01% 3310
2025
Q2
$1.92M Buy
206,562
+17,385
+9% +$152K ﹤0.01% 2775
2025
Q1
$1.84M Buy
189,177
+14,659
+8% +$181K ﹤0.01% 2732
2024
Q4
$2.11M Buy
174,518
+11,893
+7% +$145K ﹤0.01% 2739
2024
Q3
$1.78M Sell
162,625
-17,601
-10% -$179K ﹤0.01% 2811
2024
Q2
$1.62M Buy
180,226
+17,471
+11% +$122K ﹤0.01% 2912
2024
Q1
$1.33M Sell
162,755
-5,818
-3% -$47.7K ﹤0.01% 2996
2023
Q4
$1.42M Buy
168,573
+1,142
+0.7% +$13.2K ﹤0.01% 2997
2023
Q3
$2.86M Sell
167,431
-805
-0.5% -$15.8K ﹤0.01% 2603
2023
Q2
$3.91M Sell
168,236
-5,135
-3% -$100K ﹤0.01% 2460
2023
Q1
$3.06M Buy
173,371
+5,802
+3% +$138K ﹤0.01% 2561
2022
Q4
$4.56M Buy
167,569
+21,007
+14% +$437K ﹤0.01% 2390
2022
Q3
$2.53M Buy
146,562
+41,668
+40% +$795K ﹤0.01% 2687
2022
Q2
$1.83M Sell
104,894
-4,182
-4% -$68.7K ﹤0.01% 2883
2022
Q1
$1.85M Sell
109,076
-406
-0.4% -$7.66K ﹤0.01% 2976
2021
Q4
$2.97M Buy
109,482
+17,313
+19% +$518K ﹤0.01% 2752
2021
Q3
$2.73M Buy
92,169
+13,835
+18% +$449K ﹤0.01% 2814
2021
Q2
$3.01M Sell
78,334
-8,684
-10% -$297K ﹤0.01% 2747
2021
Q1
$2.65M Sell
87,018
-995
-1% -$37.3K ﹤0.01% 2765
2020
Q4
$3.36M Buy
88,013
+24,661
+39% +$1.03M ﹤0.01% 2544
2020
Q3
$1.46M Buy
63,352
+13,864
+28% +$316K ﹤0.01% 2877
2020
Q2
$1.23M Buy
49,488
+15,563
+46% +$275K ﹤0.01% 2980
2020
Q1
$338K Buy
33,925
+2,122
+7% +$31.6K ﹤0.01% 3552
2019
Q4
$457K Buy
31,803
+3,116
+11% +$44.9K ﹤0.01% 3632
2019
Q3
$398K Sell
28,687
-1,183
-4% -$14.5K ﹤0.01% 3673
2019
Q2
$438K Sell
29,870
-362
-1% -$5.24K ﹤0.01% 3666
2019
Q1
$460K Buy
30,232
+6,183
+26% +$77.1K ﹤0.01% 3600
2018
Q4
$240K Buy
24,049
+4,209
+21% +$56.9K ﹤0.01% 3786
2018
Q3
$319K Buy
+19,840
New +$348K ﹤0.01% 3807

Other funds holding REPL

Bank of New York Mellon's REPL Position: Q2 2026 in Review

Bank of New York Mellon increased its Replimune Group (REPL) stake by 15% in Q2 2026, buying an estimated $187K and bringing the position to 235,405 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2801.

Bank of New York Mellon first reported a position in REPL in Q3 2018 and has held it in 32 quarters since. The position peaked at $4.56M in Q4 2022. 75 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Bank of New York Mellon held 235,405 shares of Replimune Group worth $2.61M as of Q2 2026.
  • Bank of New York Mellon bought 30,614 Replimune Group shares in Q2 2026, an estimated $187K.
  • Replimune Group made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2801 holding.
  • Bank of New York Mellon first reported a position in Replimune Group in Q3 2018 and has held it in 32 quarters since.
  • Bank of New York Mellon's Replimune Group position peaked at $4.56M in Q4 2022.
  • 75 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.